Journal: The Journal of Biological Chemistry
Article Title: DNA polymerase η promotes nonhomologous end joining upon etoposide exposure dependent on the scaffolding protein Kap1
doi: 10.1016/j.jbc.2022.101861
Figure Lengend Snippet: Pol η deficiency leads to NHEJ repair defect and cellular hypersensitivity to ETO. A , Pol η shRNA–treated cells complemented with Flag-Pol η or not were transfected with NHEJ reporter (I-SceI endonuclease encoding plasmid and pDsRed2-N1). NHEJ repair efficiency (GFP + /DsRed + ) were analyzed by FACS after 96 h. The lower panels show the Pol η levels through immunoblotting. Tubulin: loading control. B , the recruitment of Pol η to ETO-induced DSBs is independent of its catalytic activity. The proportions of GFP-Pol η WT- or CI (catalytic inactive) mutant-expressing cells with more than 30 foci were determined. Data represent means ± SEM from three independent experiments. C , the role of Pol η in NHEJ is independent of its catalytic activity. EJ5 cells overexpressing Flag-vector, or Flag-Pol η WT, or CI were transfected with I-SceI endonuclease. NHEJ repair efficiency (GFP + ) was analyzed by FACS after 48 h. The lower panels show immunoblots indicating the Pol η levels in different conditions. D , MRC5 (NC, siPol η, and siKu80), XPV, and GFP-Pol η–complemented XPV (XPV-GFP-Pol η) cells were treated with indicated ETO and further incubated for 7 to 10 days. The number of clones was determined. Surviving fraction was expressed as a percentage of mock-treated cells. Experiment was repeated three times, giving similar results. The representative curve is shown. Error bar: s.d., n = 3. E , immunoblots indicating the Pol η and Ku80 levels in ( D ). Tubulin: loading control. DSB, double-strand break; ETO, etoposide; FACS, fluorescence activated cell sorting; NHEJ, nonhomologous end joining.
Article Snippet: Antibodies sources were as follows: mouse anti-Flag (F1804, 1:1000) from Sigma; anti-Pol η (ab17725, 1:1000), anti-γH2AX (ab11174, 1:1000), anti-Rad18 (ab57447, 1:1000), anti-DNA-PKcs (ab18356, 1:1000), and anti-Rad51 (ab133534, 1:200) from Abcam; anti-53BP1 (4937S, 1:1000) from Cell Signaling Technology; anti-Myc (MMS-150R-500, 1:1000) from Covance; anti-His (HT501–02, 1:1000) from Beijing TransGen Biotech Co, Ltd; anti-β-actin (M20010, 1:2000) from Abmart; anti-β-Tubulin (AbM59005–37-PU, 1:4000), anti-Ku80 (AbM51083-6-PU, 1:1000), and anti-Ku70 (AbM51079-4-PU, 1:1000) from Beijing Protein Innovation; anti-GFP (sc-8334, 1:500), anti-Kap1 (sc-515790, 1:1000), anti-PCNA (sc-56, 1:1000), and anti-PARP1 (sc-8007, 1:1000) from Santa Cruz Biotechnology.
Techniques: shRNA, Transfection, Plasmid Preparation, Western Blot, Activity Assay, Mutagenesis, Expressing, Incubation, Clone Assay, Fluorescence, FACS